Free. Unsubscribe any time.
Prime Medicine, Inc. (PRME)
Prime Medicine, Inc. filed 4 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 1 reporting owner, covering 4 transactions and 84,000 shares. None carries the SEC's AFF10B5ONE flag; all 4 name a plan in a footnote. 8 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2025-07-01, came 8 days after the one before it (2025-06-23) and reports 1 transaction against 1 in the filing before it.
- Its 4 plan statements rank 464th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 6 have more plan statements on file than it and 4 have fewer.
- Its 4 filings on file run from 2025-06-12 to 2025-07-01, and state one plan adoption date, 2025-03-03.
Trades in Prime Medicine, Inc. 4
- Liu David R. — 2025-06-11 · P · 21,000 shares
- Liu David R. — 2025-06-16 · P · 21,000 shares
- Liu David R. — 2025-06-23 · P · 21,000 shares
- Liu David R. — 2025-06-30 · P · 21,000 shares
Adoption dates in Prime Medicine, Inc. 1
- 2025-03-03 — stated in 4 filings
Results prints in Prime Medicine, Inc. 8
- 2025-02-28
- 2025-05-08
- 2025-07-30
- 2025-08-07
- 2025-11-07
- 2026-03-03
- 2026-05-07
- 2026-08-06
Trades before a print in Prime Medicine, Inc. 0
- 30 days before the 2025-07-30 print — 2025-06-30 · P · Liu David R. · 21,000 shares
- 37 days before the 2025-07-30 print — 2025-06-23 · P · Liu David R. · 21,000 shares
- 44 days before the 2025-07-30 print — 2025-06-16 · P · Liu David R. · 21,000 shares
- 49 days before the 2025-07-30 print — 2025-06-11 · P · Liu David R. · 21,000 shares
Interval to Prime Medicine, Inc.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- 30shortest, days
- 0no later print
Adoption dates Prime Medicine, Inc. states
- 2025-03-03 in 4 filings
Filing text: “10b5-1 trading plan adopted by the Reporting Person on March 3, 2025”
Reported results dates on file
- 2025-02-28
- 2025-05-08
- 2025-07-30
- 2025-08-07
- 2025-11-07
- 2026-03-03
- 2026-05-07
- 2026-08-06
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.